Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Deborah W Knapp

Showing results (61-70 of 77) with videos related to

Pageof 8
Sort By:
Journal of the American Veterinary Medical Association|July 30, 2019
Pathology in PracticeAshley L Leisering, Mario F Sola, Lisbeth A Ambrosius, et al.
Molecular Cancer Therapeutics|February 18, 2003
Effects of the cyclooxygenase inhibitor, piroxicam, in combination with chemotherapy on tumor response, apoptosis, and angiogenesis in a canine model of human invasive urinary bladder cancerSulma I Mohammed, Bruce A Craig, Anthony J Mutsaers, et al.
Journal of the American Veterinary Medical Association|February 10, 2004
Evaluation of cisplatin combined with piroxicam for the treatment of oral malignant melanoma and oral squamous cell carcinoma in dogsPedro A Boria, Daryl J Murry, Peter F Bennett, et al.
Cancer Research|January 26, 2002
Effects of the cyclooxygenase inhibitor, piroxicam, on tumor response, apoptosis, and angiogenesis in a canine model of human invasive urinary bladder cancerSulma I Mohammed, Peter F Bennett, Bruce A Craig, et al.
Molecular Cancer Research : MCR|March 14, 2015
Homologous Mutation to Human BRAF V600E Is Common in Naturally Occurring Canine Bladder Cancer--Evidence for a Relevant Model System and Urine-Based Diagnostic TestBrennan Decker, Heidi G Parker, Deepika Dhawan, et al.
Cancer Research Communications|May 29, 2026
Nanoparticulate Immunoactive Complex (IMAX) for local chemoimmunotherapy: From murine models to pilot canine studyYanying He, Jiaqi Zhao, Jung Suk Kim, et al.
Cancer Research Communications|June 28, 2023
Development of an Anti-canine PD-L1 Antibody and Caninized PD-L1 Mouse Model as Translational Research Tools for the Study of Immunotherapy in HumansWonkyung Oh, Alyssa Min Jung Kim, Deepika Dhawan, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|May 3, 2011
Cancer prevention interdisciplinary education program at Purdue University: overview and preliminary resultsDorothy Teegarden, Ji-Yeon Lee, Omolola Adedokun, et al.
The Journal of Urology|November 22, 2011
Subcutaneous 5-azacitidine treatment of naturally occurring canine urothelial carcinoma: a novel epigenetic approach to human urothelial carcinoma drug developmentNoah M Hahn, Patty L Bonney, Deepika Dhawan, et al.
Bladder Cancer (Amsterdam, Netherlands)|July 12, 2024
Basal and Luminal Molecular Subtypes in Naturally-Occurring Canine Urothelial Carcinoma are Associated with Tumor Immune Signatures and Dog BreedBreann C Sommer, Deepika Dhawan, Audrey Ruple, et al.
Pageof 8

Showing results (61-70 of 77) with videos related to

Sort By:
Pageof 8
Journal of the American Veterinary Medical Association|July 30, 2019
Pathology in PracticeAshley L Leisering, Mario F Sola, Lisbeth A Ambrosius, et al.
Molecular Cancer Therapeutics|February 18, 2003
Effects of the cyclooxygenase inhibitor, piroxicam, in combination with chemotherapy on tumor response, apoptosis, and angiogenesis in a canine model of human invasive urinary bladder cancerSulma I Mohammed, Bruce A Craig, Anthony J Mutsaers, et al.
Journal of the American Veterinary Medical Association|February 10, 2004
Evaluation of cisplatin combined with piroxicam for the treatment of oral malignant melanoma and oral squamous cell carcinoma in dogsPedro A Boria, Daryl J Murry, Peter F Bennett, et al.
Cancer Research|January 26, 2002
Effects of the cyclooxygenase inhibitor, piroxicam, on tumor response, apoptosis, and angiogenesis in a canine model of human invasive urinary bladder cancerSulma I Mohammed, Peter F Bennett, Bruce A Craig, et al.
Molecular Cancer Research : MCR|March 14, 2015
Homologous Mutation to Human BRAF V600E Is Common in Naturally Occurring Canine Bladder Cancer--Evidence for a Relevant Model System and Urine-Based Diagnostic TestBrennan Decker, Heidi G Parker, Deepika Dhawan, et al.
Cancer Research Communications|May 29, 2026
Nanoparticulate Immunoactive Complex (IMAX) for local chemoimmunotherapy: From murine models to pilot canine studyYanying He, Jiaqi Zhao, Jung Suk Kim, et al.
Cancer Research Communications|June 28, 2023
Development of an Anti-canine PD-L1 Antibody and Caninized PD-L1 Mouse Model as Translational Research Tools for the Study of Immunotherapy in HumansWonkyung Oh, Alyssa Min Jung Kim, Deepika Dhawan, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|May 3, 2011
Cancer prevention interdisciplinary education program at Purdue University: overview and preliminary resultsDorothy Teegarden, Ji-Yeon Lee, Omolola Adedokun, et al.
The Journal of Urology|November 22, 2011
Subcutaneous 5-azacitidine treatment of naturally occurring canine urothelial carcinoma: a novel epigenetic approach to human urothelial carcinoma drug developmentNoah M Hahn, Patty L Bonney, Deepika Dhawan, et al.
Bladder Cancer (Amsterdam, Netherlands)|July 12, 2024
Basal and Luminal Molecular Subtypes in Naturally-Occurring Canine Urothelial Carcinoma are Associated with Tumor Immune Signatures and Dog BreedBreann C Sommer, Deepika Dhawan, Audrey Ruple, et al.
Pageof 8